US GOVT TO STOP BREEDING CHIMPANZEES FOR RESEARCH
The National Institutes of Health in the US has declared that it will no longer breed chimpanzees for medical research. Although since 1995 a temporary moratorium on breeding had been in place anyway, the current decision makes it permanent. Authorities acknowledge that chimps are valuable for medical research, but that caring for them simply costs too much. Since 2000, chimps may not be euthanased after they are no longer useful for scientific studies, but must be pensioned out to a wildlife sanctuary. It can cost US$500,000 to care for a chimp over its 50-year lifespan.
Scientists differed over the impact that the new policy would have upon research. Some feel that private enterprise will breed and support the next generation. Others say that it could affect progress in finding a vaccine for Hepatitis C, since chimpanzees are the only animals which can be infected with the virus. The decision was hailed by animal rights groups.
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...